Clinical trial

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

NCT01531205

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-05-01

PhasePHASE2

Study timeline

Study start (unknown)2012-05-01Date precision: month

Registry last updated2014-11-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Androgen AblationDRUG

CabazitaxelDRUG · verified · RxNorm: cabazitaxel

Salvage TherapyDRUG

Neoadjuvant Treatment - Hormonal TherapyDRUG

Neoadjuvant Treatment - CabazitaxelDRUG

Sponsors & collaborators

H. Lee Moffitt Cancer Center and Research Institutelead sponsor

Sanoficollaborator

Mapped research locations

TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01531205 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.